Image For Activity Cover
Nicotine and Stimulant Use in Adolescents
SUD 101 Core Curriculum Overview

Curriculum overview:  While healthcare professionals are often on the front lines of treating substance use disorders, most have limited (if any) training in this area. The SUD 101 Core Curriculum was created to provide a foundation of the current research, resources, and support needed to increase healthcare professionals’ competence and confidence in the care of their patients across the continuum of care. This activity, Nicotine and Stimulant Use in Adolescents, is part of the 23-module curriculum. Please see below for a summary of module 17 out of 23:
Module 17 Overview
Title: Nicotine and Stimulant Use in Adolescents  

Presenter(s):
 
Nicholas Chadi, MD, Pediatrician Specialized in Adolescent and Addiction Medicine, Sainte-Justine University Hospital Centre; Assistant Professor of Pediatrics, University of Montreal

Module Description: With the recent increase in use of vaping devices among youth, nicotine use disorder remains prevalent in adolescents and young adults. While rates of use of illicit stimulants including cocaine, ecstasy/MDMA and methamphetamine have decreased in adolescents in recent years, misuse of prescription stimulants remains common in this age group. This module reviews recent trends in nicotine and stimulant use in adolescents in young adults. It also presents a summary of the neurobiology of nicotine, discusses the different health effects and risks of harm of nicotine and stimulants (including illicit stimulants, prescription stimulants and caffeine) and offers an overview of prevention, harm reduction and treatment strategies for youth. 

Educational Objectives:

  • Discuss recent trends in nicotine and stimulant use among adolescents
  • Describe the health risks of nicotine and stimulant drugs
  • Apply evidence-based treatment for youth with tobacco/nicotine use and stimulant misuse
Summary
Availability: On-Demand
Expires on Jan 12, 2026
Cost: FREE
Credit Offered:
1.25 CME Credits
1.25 PA-CME Credits
1.25 Other Professionals Credits
1.25 Nursing Credits
1.25 Pharmacy Credits
1.25 IPCE Credits
Recommended
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.



Funding for this initiative was made possible (in part) by grant nos. 1H79TI086770 and 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
For Buprenorphine Training Inquiries, email PCSS-MOUD.

ORN
opioidresponsenetwork.org

Powered By